Page last updated: 2024-08-21

pyrazines and Allergy, Drug

pyrazines has been researched along with Allergy, Drug in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's3 (42.86)29.6817
2010's2 (28.57)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Bellutti-Enders, F; Hartmann, K; Jamiolkowski, D; Leuppi-Taegtmeyer, A; Manjaly Thomas, ZR; Scherer Hofmeier, K; Steveling-Klein, E1
Aoyama, M; Hamasaki, Y; Imataki, O; Kida, J; Kubo, H; Ohue, Y; Oku, M; Ota, S; Uemura, M1
Adachi, D; Hattori, N; Nakamaki, T; Nakashima, H; Saito, B; Tomoyasu, S1
Brinker, A; Desai, S; Iyasu, S; Swann, J1
Boral, A; Busam, K; Esseltine, D; Gerecitano, J; Gonen, M; Goy, A; MacGregor-Cortelli, B; Neylon, E; O'Connor, OA; Sachs, D; Schenkein, D; Teruya-Feldstein, J; Wright, J1
Kleinjans, HA; Stalenhoef, AF; Stuyt, PM1

Reviews

1 review(s) available for pyrazines and Allergy, Drug

ArticleYear
Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities.
    The Journal of allergy and clinical immunology, 2020, Volume: 146, Issue:4

    Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Drug Hypersensitivity; Humans; Immunity, Innate; Immunologic Factors; Indoles; Infliximab; Interleukin 1 Receptor Antagonist Protein; Nitriles; Pandemics; Pneumonia, Viral; Pyrazines; Pyrazoles; Pyrimidines; SARS-CoV-2; Severity of Illness Index

2020

Trials

2 trial(s) available for pyrazines and Allergy, Drug

ArticleYear
Drug-induced cutaneous vasculitis in patients with non-Hodgkin lymphoma treated with the novel proteasome inhibitor bortezomib: a possible surrogate marker of response?
    British journal of haematology, 2006, Volume: 134, Issue:4

    Topics: Aged; Boronic Acids; Bortezomib; Drug Hypersensitivity; Female; Humans; Logistic Models; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Protease Inhibitors; Pyrazines; Skin; Skin Diseases, Vascular; Treatment Outcome

2006
Tolerability and effects of high doses acipimox as additional lipid-lowering therapy in familial hypercholesterolemia.
    The Netherlands journal of medicine, 1998, Volume: 53, Issue:5

    Topics: Adult; Aged; Cholesterol, VLDL; Dose-Response Relationship, Drug; Drug Hypersensitivity; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipoproteins, LDL; Male; Middle Aged; Pyrazines; Safety; Simvastatin

1998

Other Studies

4 other study(ies) available for pyrazines and Allergy, Drug

ArticleYear
Delayed flare reaction of draining vein due to subcutaneous bortezomib more likely to occur at the inner thigh.
    International journal of hematology, 2015, Volume: 101, Issue:1

    Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Drug Hypersensitivity; Erythema; Humans; Hypersensitivity, Delayed; Pyrazines; Skin; Thigh

2015
Drug-induced hypersensitivity syndrome after bortezomib treatment for refractory multiple myeloma.
    Leukemia research, 2009, Volume: 33, Issue:4

    Topics: Acyclovir; Antineoplastic Agents; Antiviral Agents; Boronic Acids; Bortezomib; Cyclosporine; Dexamethasone; Drug Hypersensitivity; Exanthema Subitum; Herpesvirus 3, Human; Herpesvirus 6, Human; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Prednisone; Pyrazines; Syndrome; Virus Activation

2009
Sitagliptin: serious allergies. Risks greater than benefits.
    Prescrire international, 2009, Volume: 18, Issue:101

    Topics: Drug Hypersensitivity; Europe; Humans; Hypoglycemic Agents; Pyrazines; Sitagliptin Phosphate; Triazoles

2009
Sitagliptin-associated drug allergy: review of spontaneous adverse event reports.
    Archives of internal medicine, 2010, Jul-12, Volume: 170, Issue:13

    Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Hypersensitivity; Female; Glucagon-Like Peptide 1; Humans; Incidence; Male; Middle Aged; Pyrazines; Retrospective Studies; Sitagliptin Phosphate; Triazoles; United States

2010